前立腺肥大症に対するオキセンドロンの使用経験 --臨床効果と血清脂質への影響について

Autor: YASUKAWA, Akihiro, NIHIRA, Hiromi, MATSUKI, Satoru, FUJII, Motohiro, FUJIWARA, Hidesuke, KITANO, Taiji, KODAMA, Mitsuto, UKAI, Rinzo, TADO, Osamu, SAGAMI, Kohji, HIMENO, Yasutoshi
Jazyk: japonština
Rok vydání: 1984
Předmět:
Zdroj: 泌尿器科紀要. 30(4):537-543
ISSN: 0018-1994
Popis: Forty-three patients with benign prostatic hyperplasia were treated with weekly i.m. injections of 400 mg oxendolone for 12 weeks. The subjective symptoms were improved in 83% of these patients. Residual urine was decreased significantly and Qmax was increased by this treatment. Serum VLDL level was suppressed significantly, whereas the levels of LDL, total cholesterol, HDL-cholesterol and triglycerides were changed little. Atherosclerotic index and the ratio of (total cholesterol--HDL-cholesterol) to (HDL-cholesterol), was not influenced by the treatment. No severe side-effect was found. These findings suggest that oxendolone is the drug of choice for non-surgical treatment of benign prostatic hyperplasia.
Databáze: OpenAIRE